Reshape Lifesciences Inc Share Price (NASDAQ: HIND)

Reshape Lifesciences Inc Stock Performance

as on October 4, 2025 at 1:29 am IST

Day's Low
Day's High
$5.3
Day's Price Range
$5.6
$5.52
3.99%
Downside
1.45%
Upside
52 Week's Low
52 Week's High
$5.04
52-Week Price Range
$16
$5.52
8.70%
Downside
189.86%
Upside

Reshape Lifesciences Inc share price movements today

Previous Close: $5.36
Open: $5.36
Volume: 216.7K
Day's Low - High: $5.3 - $5.6
52 Week Low - High: $5.04 - $16

Reshape Lifesciences Inc Historical Returns

1 Month Return: -29.18 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Reshape Lifesciences Inc Stock Fundamentals & Key Indicators

Check Reshape Lifesciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

31308200.00%

Reshape Lifesciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Reshape Lifesciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Reshape Lifesciences Inc	NA	$-	NA	NA	0.00%
Beone Medicines Ltd	NA	$40.5B	NA	NA	-3.89%
Alnylam Pharmaceuticals, Inc.	BUY	$60.4B	236.34%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$104.8B	54.64%	29.06	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$63.6B	6.23%	15.13	31.37%

Reshape Lifesciences Inc Stock’s Investor Sentiment and Interest

Investment in Reshape Lifesciences Inc Shares on INDmoney has grown by 1025.00% over the past 30 days, indicating increased transactional activity.

Time period: September 5, 2025 to October 5, 2025

Change:1025.00% versus previous 30 day period

Search interest for Reshape Lifesciences Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 5, 2025 to October 5, 2025

Change:-55% versus previous 30 day period

Reshape Lifesciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	2	2	2	2	2	1	1	2	1	1
Gross Profit	1	2	1	1	1	1	1	1	0	0
Operating Income	-9	-12	-5	-3	-3	-2	-2	-1	-2	-2
EBITDA	-8	-4	-5	-3	-3	-2	-2	-1	-1	-2
Interest Expense	-	-	0	-	-	-	-	-	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-9	-12	-2	-3	-3	-2	-1	-1	1	-2
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-9	-12	-2	-3	-3	-2	-1	-1	1	-2
Net Profit Margin	-326.56%	-435.53%	-116.40%	-154.97%	-163.99%	-112.81%	-81.17%	-68.98%	132.43%	-211.76%

Reshape Lifesciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	1	0	15	11	13	11	8	8
Gross Profit	0	0	0	0	9	6	8	6	5	5
Operating Income	-27	-22	-31	-38	-15	-12	-24	-27	-14	-6
EBITDA	-27	-19	-34	-36	-17	-18	-60	-24	-14	-6
Interest Expense	0	4	0	0	0	2	0	0	0	-
Depreciation	-	-	-	-	-	-	-	0	0	-
Income Before Tax	-25	-23	-36	-38	-75	-21	-63	-46	-11	-7
Income Tax Expense	-2	-	-2	-3	0	0	0	0	0	0
Net Income	-25	-23	-33	-81	-74	-21	-63	-46	-11	-7
Net Profit Margin	-8732.53%	-2969.62%	-2627.34%	-13375.68%	-491.80%	-191.43%	-464.31%	-411.16%	-131.22%	-89.06%

Reshape Lifesciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Net Income	-12	-2	-3	-3	-2	-1	-1	1	-2
Operating Cash Flow	-5	-5	-6	-2	-2	-1	0	-2	-4
Investing Cash Flow	0	0	0	-	3	-	-	4	10
Financing Cash Flow	0	10	2	0	5	0	-	3	6
Change in Cash	-5	5	-4	-3	-2	-1	0	1	1

Reshape Lifesciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-23	-33	-35	-74	-21	-35	-46	-11	-7
Operating Cash Flow	-20	-24	-27	-14	-8	-15	-21	-16	-4
Investing Cash Flow	0	-6	-10	-2	-2	1	0	0	-
Financing Cash Flow	16	37	33	13	11	33	3	17	0
Change in Cash	-4	6	-4	-2	0	19	-18	0	-3

Insights on Reshape Lifesciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.11M → 1.24M (in $), with an average increase of 10.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.9% return, outperforming this stock by 164.1%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 127.8% return, outperforming this stock by 227.8%
NEGATIVE IMPACT
Price Dip
In the last 1 month, HIND stock has moved down by -39.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.47M → -2.63M (in $), with an average decrease of 278.4% per quarter

About Reshape Lifesciences Inc

Vyome Holdings, Inc., formerly ReShape Lifesciences Inc., is focused on the business of advancing the development of its immuno-inflammatory assets. The Company is also focused on identifying additional opportunities.

Organisation	Reshape Lifesciences Inc
Headquarters	Harvard Square, Cambridge, MA, United States, 02138
CEO	Mr. Venkateswarlu Nelabhotla M.B.A.
E-voting on shares	Click here to vote

Key Management of Reshape Lifesciences Inc

Name	Title
Dr. Charles G. Chavdarian Ph.D.	Senior Vice President of Product Development & Regulatory CMC
Dr. Rena Patel J.D., Ph.D.	Chief Patent Counsel
Dr. Tamara Agajanov M.D.	Senior Vice President of Clinical Development
Mr. Venkateswarlu Nelabhotla M.B.A.	Co-Founder, CEO, President & Director
Dr. Shiladitya Sengupta M.Sc., Ph.D.	Co-Founder, Director and Member of Scientific & Clinical Advisory Board
Dr. Richard Fahrner Ph.D.	Chief Technology Officer
Dr. Angelo Secci M.D.	Chief Medical Officer

FAQs

What is Reshape Lifesciences Inc share price today?

Reshape Lifesciences Inc share price today is $5.52 as on October 4, 2025 at 1:29 am IST at the close of the market. Reshape Lifesciences Inc share today touched a day high of $5.6 and a low of $5.3.

What is the 52 week high and 52 week low for Reshape Lifesciences Inc share?

Reshape Lifesciences Inc share touched a 52 week high of $16 on August 15, 2025 and a 52 week low of $5.04 on September 26, 2025. Reshape Lifesciences Inc stock price today i.e. October 4, 2025 at 1:29 am IST is closed at $5.52,which is 65.50% down from its 52 week high and 9.52% up from its 52 week low.

How to invest in Reshape Lifesciences Inc Stock (HIND) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Reshape Lifesciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Reshape Lifesciences Inc Shares that will get you 0.2717 shares as per Reshape Lifesciences Inc share price of $5.52 per share as on October 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Reshape Lifesciences Inc Stock (HIND) from India?

Indian investors can start investing in Reshape Lifesciences Inc (HIND) shares with as little as ₹88.775 or $1 (as of October 5, 2025 at 11:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.75 in Reshape Lifesciences Inc stock (as per the Rupee-Dollar exchange rate as on October 5, 2025 at 11:42 pm IST). Based on Reshape Lifesciences Inc share’s latest price of $5.52 as on October 4, 2025 at 1:29 am IST, you will get 1.8116 shares of Reshape Lifesciences Inc. Learn more about fractional shares .